Top

Published in:

Open Access 01-12-2006 | Review

Celiac disease

Authors: Wolfgang Holtmeier, Wolfgang F Caspary

Published in: Orphanet Journal of Rare Diseases | Issue 1/2006

Abstract

Celiac disease is a chronic intestinal disease caused by intolerance to gluten. It is characterized by immune-mediated enteropathy, associated with maldigestion and malabsorption of most nutrients and vitamins. In predisposed individuals, the ingestion of gluten-containing food such as wheat and rye induces a flat jejunal mucosa with infiltration of lymphocytes. The main symptoms are: stomach pain, gas, and bloating, diarrhea, weight loss, anemia, edema, bone or joint pain. Prevalence for clinically overt celiac disease varies from 1:270 in Finland to 1:5000 in North America. Since celiac disease can be asymptomatic, most subjects are not diagnosed or they can present with atypical symptoms. Furthermore, severe inflammation of the small bowel can be present without any gastrointestinal symptoms. The diagnosis should be made early since celiac disease causes growth retardation in untreated children and atypical symptoms like infertility or neurological symptoms. Diagnosis requires endoscopy with jejunal biopsy. In addition, tissue-transglutaminase antibodies are important to confirm the diagnosis since there are other diseases which can mimic celiac disease. The exact cause of celiac disease is unknown but is thought to be primarily immune mediated (tissue-transglutaminase autoantigen); often the disease is inherited. Management consists in life long withdrawal of dietary gluten, which leads to significant clinical and histological improvement. However, complete normalization of histology can take years.

Goldstein NS: Non-gluten sensitivity-related small bowel villous flattening with increased intraepithelial lymphocytes: not all that flattens is celiac sprue. Am J Clin Pathol. 2004, 121: 546-550. 10.1309/10FC-NCTC-56NM-N0YE.PubMed

Ciclitira PJ: AGA technical review on celiac sprue. Gastroenterology. 2001, 120: 1526-1540.PubMed

Farrell RJ, Kelly CP: Celiac sprue. N Engl J Med. 2002, 346: 180-198. 10.1056/NEJMra010852.PubMed

Abdulkarim AS, Murray JA: The diagnosis of coeliac disease. Aliment Pharmacol Ther. 2003, 17: 987-995. 10.1046/j.1365-2036.2003.01442.x.PubMed

Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, Fasano A: Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol. 1998, 33: 494-498. 10.1080/00365529850172052.PubMed

Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, Coppa GV, Giorgi PL: Coeliac disease in the year 2000: exploring the iceberg. Lancet. 1994, 343: 200-203. 10.1016/S0140-6736(94)90989-X.PubMed

Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Hopfl P, Knip M: Prevalence of Celiac disease among children in Finland. N Engl J Med. 2003, 348: 2517-2524. 10.1056/NEJMoa021687.PubMed

McLoughlin R, Sebastian SS, Qasim A, McNamara D, O'Connor HJ, Buckley M, O'Morain C: Coeliac disease in Europe. Aliment Pharmacol Ther. 2003, 18: 45-48. 10.1046/j.1365-2036.18.s3.1.x.PubMed

Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J, Mack D, Patel D, Moher D: The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review. Gastroenterology. 2005, 128: S57-S67. 10.1053/j.gastro.2005.02.014.PubMed

10.

Collin P, Reunala T, Rasmussen M, Kyronpalo S, Pehkonen E, Laippala P, Maki M: High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol. 1997, 32: 1129-1133.PubMed

11.

MacDonald WC, Dobbins WO, Rubin CE: Studies on the familial nature of celiac sprue using biopsy of the small intestine. N Engl J Med. 1968, 272: 448-456.

12.

Auricchio S, Mazzacca G, Tosi R, Visakorpi J, Maki M, Polanco I: Coeliac disease as a familial condition: Identification of asymptomatic coeliac patients within family groups. Gastroenterology Intl. 1988, 1: 25-31.

13.

Kemppainen T, Kroger H, Janatuinen E, Arnala I, Kosma VM, Pikkarainen P, Julkunen R, Jurvelin J, Alhava E, Uusitupa M: Osteoporosis in adult patients with celiac disease. Bone. 1999, 24: 249-255. 10.1016/S8756-3282(98)00178-1.PubMed

14.

Collin P, Maki M: Associated disorders in coeliac disease: clinical aspects. Scand J Gastroenterol. 1994, 29: 769-775.PubMed

15.

Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR: The clinical pattern of subclinical silent celiac disease: An analysis on 1026 consecutive cases. Am J Gastroenterol. 1999, 94: 691-696.PubMed

16.

Fasano A: Celiac disease-how to handle a clinical chameleon. N Engl J Med. 2003, 348: 2568-2570. 10.1056/NEJMe030050.PubMed

17.

Collin P, Kaukinen K, Maki M: Clinical features of celiac disease today. Dig Dis. 1999, 17: 100-106. 10.1159/000016911.PubMed

18.

Weinstein WM: Latent celiac sprue. Gastroenterology. 1974, 66: 489-493.PubMed

19.

Holmes GK: Potential and latent coeliac disease. Eur J Gastroenterol Hepatol. 2001, 13: 1057-1060. 10.1097/00042737-200109000-00010.PubMed

20.

Maki M, Holm K, Koskimies S, Hallstrom O, Visakorpi JK: Normal small bowel biopsy followed by coeliac disease. Arch Dis Child. 1990, 65: 1137-1141.PubMedCentralPubMed

21.

Maki M, Holm K, Collin P, Savilahti E: Increase in g/d T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease. Gut. 1991, 32: 1412-1414.PubMedCentralPubMed

22.

Collin P, Helin H, Maki M, Hallstrom O, Karvonen AL: Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsy findings. Scand J Gastroenterol. 1993, 28: 595-598.PubMed

23.

Picarelli A, Maiuri L, Mazzilli MC, Coletta S, Ferrante P, Di Giovambattista F, Greco M, Torsoli A, Auricchio S: Gluten-sensitive disease with mild enteropathy. Gastroenterology. 1996, 111: 608-616. 10.1053/gast.1996.v111.pm8780564.PubMed

24.

Ferguson A, Arranz E, O'Mahony S: Clinical and pathological spectrum of coeliac disease – active, silent, latent, potential. Gut. 1993, 34: 150-151.PubMedCentralPubMed

25.

Marsh MN: Clinical and pathological spectrum of coeliac disease. Gut. 1993, 34: 1740-PubMedCentralPubMed

26.

Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD: Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology. 2001, 121: 1329-1338. 10.1053/gast.2001.29572.PubMed

27.

Zimmer KP: Klinische Bedeutung nichtklassischer Zöliakieformen. Deutsches Ärzteblatt. 2001, 98: A3285-A3292.

28.

Holmes GK: Non-malignant complications of coeliac disease. Acta Paediatr Suppl. 1996, 412: 68-75.PubMed

29.

Kumar V, Rajadhyaksha M, Wortsman J: Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol. 2001, 8: 678-685. 10.1128/CDLI.8.4.678-685.2001.PubMedCentralPubMed

30.

Collin P, Kaukinen K, Valimaki M, Salmi J: Endocrinological disorders and celiac disease. Endocr Rev. 2002, 23: 464-483. 10.1210/er.2001-0035.PubMed

31.

Alaedini A, Green PH: Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med. 2005, 142: 289-298.PubMed

32.

Crabbe PA, Heremans JF: Selective IgA deficiency with steatorrhoea. A new syndrome. Am J Med. 1967, 42: 319-326. 10.1016/0002-9343(67)90031-9.PubMed

33.

Collin P, Maki M, Keyrilainen O, Hallstrom O, Reunala T, Pasternack A: Selective IgA deficiency and coeliac disease. Scand J Gastroenterol. 1992, 27: 367-371.PubMed

34.

Holmes GK, Prior P, Lane MR, Pope D, Allan RN: Malignancy in coeliac disease-effect of a gluten free diet. Gut. 1989, 30: 333-338.PubMedCentralPubMed

35.

Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A: Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis. Gastroenterology. 2002, 123: 1428-1435. 10.1053/gast.2002.36585.PubMed

36.

Loftus CG, Loftus EV Jr: Cancer risk in celiac disease. Gastroenterology. 2002, 123: 1726-1729. 10.1053/gast.2002.36850.PubMed

37.

Marsh MN, Crowe PT: Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol. 1995, 9: 273-293. 10.1016/0950-3528(95)90032-2.PubMed

38.

Iltanen S, Holm K, Ashorn M, Ruuska T, Laippala P, Maki M: Changing jejunal g/d T cell receptor (TCR)-bearing intraepithelial lymphocyte density in coeliac disease. Clin Exp Immunol. 1999, 117: 51-55. 10.1046/j.1365-2249.1999.00948.x.PubMedCentralPubMed

39.

Holtmeier W, Rowell DL, Nyberg A, Kagnoff MF: Distinct d T cell receptor repertoires in monozygotic twins concordant for coeliac disease. Clin Exp Immunol. 1997, 107: 148-157. 10.1046/j.1365-2249.1997.d01-887.x.PubMedCentralPubMed

40.

Kaukinen K, Maki M, Partanen J, Sievanen H, Collin P: Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci. 2001, 46: 879-887. 10.1023/A:1010729207320.PubMed

41.

Marsh MN: Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology. 1992, 102: 330-354.PubMed

42.

Oberhuber G, Granditsch G, Vogelsang H: The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999, 11: 1185-1194.PubMed

43.

Maki M, Hallstrom O, Huupponen T, Vesikari T, Visakorpi JK: Increased prevalence of coeliac disease in diabetes. Arch Dis Child. 1984, 59: 739-742.PubMedCentralPubMed

44.

Holtmeier W, Caspary WF: Antibody diagnosis in sprue/celiac diseas. Z Gastroenterol. 1998, 36: 587-597.PubMed

45.

Murray JA, Green PH: Biopsy is the gold standard of diagnosis of celiac sprue. Gastroenterology. 1999, 116: 1273-1274. 10.1016/S0016-5085(99)70040-5.PubMed

46.

Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ: Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999, 94: 888-894. 10.1111/j.1572-0241.1999.983_f.x.PubMed

47.

Dieterich W, Laag E, Schopper H, Volta U, Ferguson A, Gillett H, Riecken EO, Schuppan D: Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology. 1998, 115: 1317-1321. 10.1016/S0016-5085(98)70007-1.PubMed

48.

Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T: Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol. 2000, 95: 1253-1257. 10.1111/j.1572-0241.2000.02018.x.PubMed

49.

Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabo IR, Sarnesto A, Savilahti E, Collin P, Maki M: Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 1998, 115: 1322-1328. 10.1016/S0016-5085(98)70008-3.PubMed

50.

Tesei N, Sugai E, Vazquez H, Smecuol E, Niveloni S, Mazure R, Moreno ML, Gomez JC, Maurino E, Bai JC: Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies. Aliment Pharmacol Ther. 2003, 17: 1415-1423. 10.1046/j.1365-2036.2003.01595.x.PubMed

51.

Leon F, Pena R, Camarero C, Sanchez L, Eiras P, Del Amo A, Bootello A, Roy G: Limitations of anti-guinea pig liver transglutaminase IgA in screening of celiac disease. Gastroenterology. 2001, 120: 586-587.PubMed

52.

Schuppan D, Hahn EG: IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening. Eur J Gastroenterol Hepatol. 2001, 13: 635-637. 10.1097/00042737-200106000-00004.PubMed

53.

Osman AA, Richter T, Stern M, Conrad K, Henker J, Brandsch C, Zimmer KP, Mothes T: Production of recombinant human tissue transglutaminase using the baculovirus expression system, and its application for serological diagnosis of coeliac disease. Eur J Gastroenterol Hepatol. 2002, 14: 1217-1223. 10.1097/00042737-200211000-00009.PubMed

54.

Wong RC, Wilson RJ, Steele RH, Radford-Smith G, Adelstein S: A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol. 2002, 55: 488-494.PubMedCentralPubMed

55.

Freeman HJ: Strongly positive tissue transglutaminase antibody assays without celiac disease. Can J Gastroenterol. 2004, 18: 25-28.PubMed

56.

Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG: Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005, 40: 1-19. 10.1097/00005176-200501000-00001.PubMed

57.

Schuppan D: Current concepts of celiac disease pathogenesis. Gastroenterology. 2000, 119: 234-242. 10.1053/gast.2000.8521.PubMed

58.

Collin P, Kaukinen K, Vogelsang H, Korponay-Szabo I, Sommer R, Schreier E, Volta U, Granito A, Veronesi L, Mascart F, Ocmant A, Ivarsson A, Lagerqvist C, Burgin-Wolff A, Hadziselimovic F, Furlano RI, Sidler MA, Mulder CJ, Goerres MS, Mearin ML, Ninaber MK, Gudmand-Hoyer E, Fabiani E, Catassi C, Tidlund H, Alainentalo L, Maki M: Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol. 2005, 17: 85-91. 10.1097/00042737-200501000-00017.PubMed

59.

Korponay-Szabo IR, Dahlbom I, Laurila K, Koskinen S, Woolley N, Partanen J, Kovacs JB, Maki M, Hansson T: Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut. 2003, 52: 1567-1571. 10.1136/gut.52.11.1567.PubMedCentralPubMed

60.

Lock R, Stevens S, Pitcher MC, Unsworth DJ: Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?. Eur J Gastroenterol Hepatol. 2004, 16: 467-470. 10.1097/00042737-200405000-00005.PubMed

61.

Fabiani E, Catassi C: The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol. 2001, 13: 659-665. 10.1097/00042737-200106000-00008.PubMed

62.

Cataldo F, Lio D, Marino V, Picarelli A, Ventura A, Corazza GR, the Working Groups on Celiac Disease of SIGEP and Club del Tenue: IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Gut. 2000, 47: 366-369. 10.1136/gut.47.3.366.PubMedCentralPubMed

63.

Sugai E, Selvaggio G, Vazquez H, Viola M, Mazure R, Pizarro B, Smecuol E, Flores D, Pedreira S, Maurino E, Gomez JC, Bai JC: Tissue transglutaminase antibodies in celiac disease: assessment of a commercial kit. Am J Gastroenterol. 2000, 95: 2318-2322. 10.1111/j.1572-0241.2000.02259.x.PubMed

64.

Kaukinen K, Sulkanen S, Maki M, Collin P: IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol. 2002, 14: 311-315. 10.1097/00042737-200203000-00017.PubMed

65.

Tursi A, Brandimarte G, Giorgetti GM: Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease. J Clin Gastroenterol. 2003, 37: 387-391. 10.1097/00004836-200311000-00007.PubMed

66.

Collin P, Maki M, Kaukinen K: Complete small intestine mucosal recovery is obtainable in the treatment of celiac disease. Gastrointest Endosc. 2004, 59: 158-159. 10.1016/S0016-5107(03)01311-7.PubMed

67.

Vahedi K, Mascart F, Mary JY, Laberenne JE, Bouhnik Y, Morin MC, Ocmant A, Velly C, Colombel JF, Matuchansky C: Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol. 2003, 98: 1079-1087. 10.1111/j.1572-0241.2003.07284.x.PubMed

68.

National Institutes of Health Consensus Development Conference Statement on Celiac Disease, June 28–30, 2004. Gastroenterology. 128: S1-S9. 10.1053/j.gastro.2005.02.007.

69.

Kasarda DD, Okita TW, Bernardin JE, Baecker PA, Nimmo CC, Lew EJ, Dietler MD, Greene FC: Nucleic acid (cDNA) and amino acid sequences of a-type gliadins from wheat (Triticum aestivum L.). Proc Natl Acad Sci USA. 1984, 81: 4712-PubMedCentralPubMed

70.

Hardman CM, Garioch JJ, Leonard JN, Thomas HJ, Walker MM, Lortan JE, Lister A, Fry L: Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med. 1997, 337: 1884-1887. 10.1056/NEJM199712253372604.PubMed

71.

Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma VM, Jarvinen RM, Uusitupa MI, Julkunen RJ: A comparison of diets with and without oats in adults with celiac disease. N Engl J Med. 1995, 333: 1033-1037. 10.1056/NEJM199510193331602.PubMed

72.

Janatuinen EK, Kemppainen TA, Pikkarainen PH, Holm KH, Kosma VM, Uusitupa MI, Maki M, Julkunen RJ: Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut. 2000, 46: 327-331. 10.1136/gut.46.3.327.PubMedCentralPubMed

73.

Janatuinen EK, Kemppainen TA, Julkunen RJK, Kosma VM, Maki M, Heikkinen M, Uusitupa MIJ: No harm from five year ingestion of oats in coeliac disease. Gut. 2002, 50: 332-335. 10.1136/gut.50.3.332.PubMedCentralPubMed

74.

Hogberg L, Laurin P, Falth-Magnusson K, Grant C, Grodzinsky E, Jansson G, Ascher H, Browaldh L, Hammersjo JA, Lindberg E, Myrdal U, Stenhammar L: Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut. 2004, 53: 649-654. 10.1136/gut.2003.026948.PubMedCentralPubMed

75.

Vader LW, de Ru A, van der WY, Kooy YM, Benckhuijsen W, Mearin ML, Drijfhout JW, van Veelen P, Koning F: Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med. 2002, 195: 643-649. 10.1084/jem.20012028.PubMedCentralPubMed

76.

Lundin KE, Nilsen EM, Scott HG, Loberg EM, Gjoen A, Bratlie J, Skar V, Mendez E, Lovik A, Kett K: Oats induced villous atrophy in coeliac disease. Gut. 2003, 52: 1649-1652. 10.1136/gut.52.11.1649.PubMedCentralPubMed

77.

Peraaho M, Kaukinen K, Mustalahti K, Vuolteenaho N, Maki M, Laippala P, Collin P: Effect of an oats-containing gluten-free diet on symptoms and quality of life in coeliac disease. A randomized study. Scand J Gastroenterol. 2004, 39: 27-31.PubMed

78.

Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK: Revised criteria for diagnosis of coeliac disease. Arch Dis Child. 1990, 65: 909-911.

79.

Selby WS, Painter D, Collins A, Faulkner-Hogg KB, Loblay RH: Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten. Scand J Gastroenterol. 1999, 34: 909-914. 10.1080/003655299750025390.PubMed

80.

Lee SK, Lo W, Memeo L, Rotterdam H, Green PHR: Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointes Endoscopy. 2003, 57: 187-191.

81.

Mustalahti K, Collin P, Sievanen H, Salmi J, Maki M: Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet. 1999, 354: 744-745. 10.1016/S0140-6736(99)01990-X.PubMed

82.

Ventura A, Magazzu G, Greco L: Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology. 1999, 117: 297-303. 10.1053/gast.1999.0029900297.PubMed

83.

Sategna GC, Solerio E, Scaglione N, Aimo G, Mengozzi G: Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut. 2001, 49: 502-505. 10.1136/gut.49.4.502.PubMedCentral

84.

Viljamaa M, Kaukinen K, Huhtala H, Kyronpalo S, Rasmussen M, Collin P: Coeliac disease, autoimmune diseases and gluten exposure. Scand J Gastroenterol. 2005, 40: 437-443.PubMed

85.

Abdulkarim AS, Burgart LJ, See J, Murray JA: Etiology of nonresponsive celiac disease: Results of a systematic approach. Am J Gastroenterol. 2002, 97: 2016-2021. 10.1111/j.1572-0241.2002.05917.x.PubMed

86.

Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C: Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut. 2004, 53: 536-541. 10.1136/gut.2003.023440.PubMedCentralPubMed

87.

Tursi A, Brandimarte G, Giorgetti GM: High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003, 98: 839-843. 10.1111/j.1572-0241.2003.07379.x.PubMed

88.

Freeman HJ, Chiu BK: Small bowel malignant lymphoma complicating celiac sprue and the mesenteric lymph node cavitation syndrome. Gastroenterology. 1986, 90: 2008-2012.PubMed

89.

Ryan BM, Kelleher D: Refractory celiac disease. Gastroenterology. 2000, 119: 243-251. 10.1053/gast.2000.8530.PubMed

90.

Fasano A: European and North American populations should be screened for coeliac disease. Gut. 2003, 52: 168-169. 10.1136/gut.52.2.168.PubMedCentralPubMed

91.

Kumar PJ: European and North American populations should be screened for coeliac disease. Gut. 2003, 52: 170-171. 10.1136/gut.52.2.170.PubMedCentralPubMed

92.

Card TR, West J, Holmes GK: Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther. 2004, 20: 769-775. 10.1111/j.1365-2036.2004.02177.x.PubMed

93.

Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, Gabrielli A, Leoni P, Carroccio A, Baldassarre M, Bertolani P, Caramaschi P, Sozzi M, Guariso G, Volta U, Corazza GR: Risk of non-Hodgkin lymphoma in celiac disease. JAMA. 2002, 287: 1413-1419. 10.1001/jama.287.11.1413.PubMed

94.

Molberg O, Solheim FN, Jensen T, Lundin KE, Arentz-Hansen H, Anderson OD, Kjersti UA, Sollid LM: Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology. 2003, 125: 337-344. 10.1016/S0016-5085(03)00890-4.PubMed

95.

Molberg O, Uhlen AK, Jensen T, Flaete NS, Fleckenstein B, Arentz-Hansen H, Raki M, Lundin KE, Sollid LM: Mapping of gluten T-cell epitopes in the bread wheat ancestors: Implications for celiac disease. Gastroenterology. 2005, 128: 393-401. 10.1053/j.gastro.2004.11.003.PubMed

96.

Sollid LM: Molecular basis of celiac disease. Annu Rev Immunol. 2000, 18: 53-81. 10.1146/annurev.immunol.18.1.53.PubMed

97.

Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM: Gliadin-specific, HLA-DQ(a 1*b 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med. 0501, 178: 187-196. 10.1084/jem.178.1.187.

98.

Molberg O, Mcadam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM: Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med. 1998, 4: 713-717. 10.1038/nm0698-713.PubMed

99.

van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G, Koning F: Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol. 1998, 161: 1585-1588.PubMed

100.

Quarsten H, Molberg O, Fugger L, Mcadam SN, Sollid LM: HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur J Immunol. 1999, 29: 2506-2514. 10.1002/(SICI)1521-4141(199908)29:08<2506::AID-IMMU2506>3.0.CO;2-9.PubMed

101.

Molberg O, McAdam S, Lundin KEA, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM: T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol. 2001, 31: 1317-1323. 10.1002/1521-4141(200105)31:5<1317::AID-IMMU1317>3.0.CO;2-I.PubMed

102.

Benahmed M, Mention JJ, Matysiak-Budnik T, Cerf-Bensussan N: Celiac disease: A future without gluten-free diet?. Gastroenterology. 2003, 125: 1264-1267. 10.1016/j.gastro.2003.07.002.PubMed

103.

Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997, 3: 797-801. 10.1038/nm0797-797.PubMed

104.

Sollid LM, Molberg O, McAdam S, Lundin KE: Autoantibodies in coeliac disease: tissue transglutaminase-guilt by association?. Gut. 1997, 41: 851-852.PubMedCentralPubMed

105.

Halttunen T, Maki M: Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology. 1999, 116: 566-572. 10.1016/S0016-5085(99)70178-2.PubMed

106.

Arentz-Hansen H, Mcadam SN, Molberg O, Fleckenstein B, Lundin KE, Jorgensen TJ, Jung G, Roepstorff P, Sollid LM: Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology. 2002, 123: 803-809. 10.1053/gast.2002.35381.PubMed

107.

Vader W, Kooy Y, van Veelen P, de Ru A, Harris D, Benckhuijsen W, Pena S, Mearin L, Drijfhout JW, Koning F: The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology. 2002, 122: 1729-1737. 10.1053/gast.2002.33606.PubMed

108.

Holtmeier W, Caspary WF: Identification of toxic gliadin fragments – new therapeutic options for patients suffering from coeliac disease (nontropical sprue)?. Z Gastroenterol. 2002, 40: 999-1000. 10.1055/s-2002-36155.

109.

Schuppan D, Hahn EG: Biomedicine: Gluten and the gut-lessons for immune regulation. Science. 2002, 297: 2218-2220. 10.1126/science.1077572.PubMed

110.

Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C: Structural basis for gluten intolerance in celiac sprue. Science. 2002, 297: 2275-2279. 10.1126/science.1074129.PubMed

111.

Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV: In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med. 2000, 6: 337-342. 10.1038/73200.PubMed

112.

Arentz-Hansen H, Korner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, Mcadam SN: The intestinal T cell response to a-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med. 2000, 191: 603-612. 10.1084/jem.191.4.603.PubMedCentralPubMed

113.

Mcadam SN, Sollid LM: Getting to grips with gluten. Gut. 2000, 47: 743-745. 10.1136/gut.47.6.743.PubMedCentralPubMed

114.

Hausch F, Shan L, Santiago NA, Gray GM, Khosla C: Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol. 2002, 283: G996-G1003.PubMed

115.

Celiac Sprue Research Foundation. [http://www.celiacsprue.org/]

116.

Koning F, Vader W: Gluten peptides and celiac disease. Science. 2003, 299: 513-515. 10.1126/science.299.5606.513.PubMed

117.

Wong RC, Steele RH, Reeves GE, Wilson RJ, Pink A, Adelstein S: Antibody and genetic testing in coeliac disease. Pathology. 2003, 35: 285-304. 10.1080/00313020307527.PubMed

Title: Celiac disease
Authors: Wolfgang Holtmeier
Wolfgang F Caspary
Publication date: 01-12-2006
Publisher: BioMed Central
Published in: Orphanet Journal of Rare Diseases / Issue 1/2006
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/1750-1172-1-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Celiac disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2006

Solitary median maxillary central incisor (SMMCI) syndrome

Primary sclerosing cholangitis

Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40

Congenital Cataracts – Facial Dysmorphism – Neuropathy

Thromboangiitis obliterans (Buerger's disease)

Retinoblastoma